Anti-Cancer Treatment - 12th International Congress: 4-7 February 2002, Paris, France

Edith A. Perez

Anti-Cancer Treatment - 12th International Congress: 4-7 February 2002, Paris, France

Edith A. Perez

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Article

Abstract

The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.

Original language	English (US)
Pages (from-to)	222-223
Number of pages	2
Journal	IDrugs
Volume	5
Issue number	3
State	Published - Dec 1 2002

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

Fingerprint Dive into the research topics of 'Anti-Cancer Treatment - 12th International Congress: 4-7 February 2002, Paris, France'. Together they form a unique fingerprint.

Cite this

Perez, E. A. (2002). Anti-Cancer Treatment - 12th International Congress: 4-7 February 2002, Paris, France. IDrugs, 5(3), 222-223.

@article{cb0d6ecf5b38497b9fb2b12d28ed390d,

title = "Anti-Cancer Treatment - 12th International Congress: 4-7 February 2002, Paris, France",

abstract = "The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.",

author = "Perez, {Edith A.}",

year = "2002",

month = dec,

day = "1",

language = "English (US)",

volume = "5",

pages = "222--223",

journal = "IDrugs : the investigational drugs journal",

issn = "1369-7056",

publisher = "Current Drugs Ltd.",

number = "3",

}

TY - JOUR

T1 - Anti-Cancer Treatment - 12th International Congress

T2 - 4-7 February 2002, Paris, France

AU - Perez, Edith A.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.

AB - The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.

UR - http://www.scopus.com/inward/record.url?scp=0141784084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141784084&partnerID=8YFLogxK

M3 - Article

C2 - 15562331

AN - SCOPUS:0141784084

VL - 5

SP - 222

EP - 223

JO - IDrugs : the investigational drugs journal

JF - IDrugs : the investigational drugs journal

SN - 1369-7056

IS - 3

ER -